215 related articles for article (PubMed ID: 226900)
21. The dynamics of cGMP metabolism in neuroblastoma N1E-115 cells determined by 18O labeling of guanine nucleotide alpha-phosphoryls.
Graeff RM; Walseth TF; Goldberg ND
Neurochem Res; 1987 Jun; 12(6):551-60. PubMed ID: 2439934
[TBL] [Abstract][Full Text] [Related]
22. Implications of PDE4 structure on inhibitor selectivity across PDE families.
Ke H
Int J Impot Res; 2004 Jun; 16 Suppl 1():S24-7. PubMed ID: 15224132
[TBL] [Abstract][Full Text] [Related]
23. Characterization of cyclic nucleotide phosphodiesterases from cultured bovine aortic endothelial cells.
Lugnier C; Schini VB
Biochem Pharmacol; 1990 Jan; 39(1):75-84. PubMed ID: 2153383
[TBL] [Abstract][Full Text] [Related]
24. Cyclic nucleotide content of the rat anococcygeus during relaxations induced by drugs or by non-adrenergic, non-cholinergic field stimulation.
Mirzazadeh S; Hobbs AJ; Tucker JF; Gibson A
J Pharm Pharmacol; 1991 Apr; 43(4):247-51. PubMed ID: 1676736
[TBL] [Abstract][Full Text] [Related]
25. Resolution of soluble cyclic nucleotide phosphodiesterase isoenzymes, from liver and hepatocytes, identifies a novel IBMX-insensitive form.
Lavan BE; Lakey T; Houslay MD
Biochem Pharmacol; 1989 Nov; 38(22):4123-36. PubMed ID: 2480793
[TBL] [Abstract][Full Text] [Related]
26. Hydrolysis of N-methyl-D-aspartate receptor-stimulated cAMP and cGMP by PDE4 and PDE2 phosphodiesterases in primary neuronal cultures of rat cerebral cortex and hippocampus.
Suvarna NU; O'Donnell JM
J Pharmacol Exp Ther; 2002 Jul; 302(1):249-56. PubMed ID: 12065724
[TBL] [Abstract][Full Text] [Related]
27. Cyclic AMP-specific phosphodiesterase inhibitor rolipram and RO-20-1724 promoted apoptosis in HL60 promyelocytic leukemic cells via cyclic AMP-independent mechanism.
Zhu WH; Majluf-Cruz A; Omburo GA
Life Sci; 1998; 63(4):265-74. PubMed ID: 9698035
[TBL] [Abstract][Full Text] [Related]
28. Differences and similarities between guanosine 3',5'-cyclic monophosphate phosphodiesterase and adenosine 3',5'-cyclic monophosphate phosphodiesterase activities in neuroblastoma cells in culture.
Prasad KN; Becker G; Tripathy K
Proc Soc Exp Biol Med; 1975 Jul; 149(3):757-62. PubMed ID: 167381
[TBL] [Abstract][Full Text] [Related]
29. Calcium-dependent regulation of guanosine 3',5'-monophosphate in renal cortex: effects of ionophore A23187 and tetracaine and evidence for independent control of adenosine 3',5'-monophosphate.
DeRubertis FR; Craven PA
Metabolism; 1976 Oct; 25(10):1113-27. PubMed ID: 184365
[TBL] [Abstract][Full Text] [Related]
30. Pig aortic endothelial-cell cyclic nucleotide phosphodiesterases. Use of phosphodiesterase inhibitors to evaluate their roles in regulating cyclic nucleotide levels in intact cells.
Souness JE; Diocee BK; Martin W; Moodie SA
Biochem J; 1990 Feb; 266(1):127-32. PubMed ID: 2155604
[TBL] [Abstract][Full Text] [Related]
31. Role of selective cyclic GMP phosphodiesterase inhibition in the myorelaxant actions of M&B 22,948, MY-5445, vinpocetine and 1-methyl-3-isobutyl-8-(methylamino)xanthine.
Souness JE; Brazdil R; Diocee BK; Jordan R
Br J Pharmacol; 1989 Nov; 98(3):725-34. PubMed ID: 2480168
[TBL] [Abstract][Full Text] [Related]
32. The identification and characterization of two cyclic nucleotide phosphodiesterases from bovine adrenal medulla.
Sabatine JM; Coffee CJ
Arch Biochem Biophys; 1986 Aug; 249(1):95-105. PubMed ID: 3017224
[TBL] [Abstract][Full Text] [Related]
33. Selective phosphodiesterase inhibition and alterations of cardiac function by alkylated xanthines.
Mushlin P; Boerth RC; Wells JN
Mol Pharmacol; 1981 Jul; 20(1):179-89. PubMed ID: 6270531
[No Abstract] [Full Text] [Related]
34. Do conventional plasma cyclic nucleotide phosphodiesterase inhibitors really work in all situations?
Wood PJ; Pao G; Ross G; Smith C
Clin Chim Acta; 1981 Sep; 115(3):405-8. PubMed ID: 6271425
[No Abstract] [Full Text] [Related]
35. [Pharmacodynamic aspects of theophylline].
Marmo E
Clin Ter; 1983 Jul; 106(2):87-94. PubMed ID: 6313282
[No Abstract] [Full Text] [Related]
36. [Modern representations of multiple forms of cyclic nucleotide phosphodiesterases in mammalian tissues].
Medvedeva MV
Biokhimiia; 1995 Mar; 60(3):364-86. PubMed ID: 7734612
[TBL] [Abstract][Full Text] [Related]
37. A prenylated flavonol, sophoflavescenol: a potent and selective inhibitor of cGMP phosphodiesterase 5.
Shin HJ; Kim HJ; Kwak JH; Chun HO; Kim JH; Park H; Kim DH; Lee YS
Bioorg Med Chem Lett; 2002 Sep; 12(17):2313-6. PubMed ID: 12161123
[TBL] [Abstract][Full Text] [Related]
38. Cyclic nucleotide phosphodiesterase in heart and aorta of spontaneously hypertensive rats.
Sharma RV; Bhalla RC
Biochim Biophys Acta; 1978 Oct; 526(2):479-88. PubMed ID: 214127
[No Abstract] [Full Text] [Related]
39. Papaverine and Ro 20-1724 inhibit cyclic nucleotide phosphodiesterase activity and increase cyclic AMP levels in psoriatic epidermis in vitro.
Rusin LJ; Duell EA; Voorhees JJ
J Invest Dermatol; 1978 Aug; 71(2):154-6. PubMed ID: 210235
[TBL] [Abstract][Full Text] [Related]
40. Opposite regulatory effects of cAMP and cGMP on sugar uptake in rat thymocytes.
Segal J
Am J Physiol; 1987 May; 252(5 Pt 1):E588-94. PubMed ID: 2437804
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
